Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 861-866

  Wang, Jun ^a,b   Chen, Yue ^a,b   Chen, Baoan ^a,b   Ding, Jiahua ^a,b   Xia, Guohua ^a,b   Gao, Chong ^a,b   Cheng, Jian ^a,b   Jin, Nan ^a,b   Zhou, Ying ^a,b   Li, Xiaomao ^a,b   Tang, Meng ^c   Wang, Xue Mei ^c  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SAARLAND UNIVERSITY   (Germany)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

Fe3O4; Magnetic nanoparticles; Mice; Tissue distribution

Indexed keywords

MAGNETIC NANOPARTICLE; MAGNETITE; DRUG CARRIER; MAGNETITE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD BRAIN BARRIER; BRAIN LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; MOUSE; NANOANALYSIS; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; PRECIPITATION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; DRUG DELIVERY SYSTEM; INSTITUTE FOR CANCER RESEARCH MOUSE; NANOMEDICINE; ULTRASTRUCTURE;

MUS;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FERROSOFERRIC OXIDE; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; SPECTROPHOTOMETRY, ATOMIC; TISSUE DISTRIBUTION;

EID: 79952117443     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S13662     Document Type: Article

References (19)

1. Li ZQ, Chen ZM. Preparation characterization and application of nano magnetic polymer materials. Chem Ind Times. 2007;21(6): 57-60.
2. Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215-223.
3. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idec JM, Jacobs PM. Preclinical safety and pharmacokinetic prof ile of Ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol. 2006;41(3):313-324.
4. Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater. 2005;293(1):483-496.
5. Chen BA, Cheng J, Wu YN, et al. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. Int J Nanomedicine. 2009; 4(1):73-78.
6. Chen BA, Cheng J, Shen MF, et al. Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells. Int J Nanomedicine. 2009;4(1): 65-71.
7. Powers KW, Palazuelos M, Moudgil BM. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology. 2007;1(1):142-151.
8. Chen BA, Lai BB, Cheng J, et al. Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo. Int J Nanomedicine. 2009;4: 201-208.
9. Jain PK, Morales MA, Sahoo SK, Leslie-Pelecky D, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2(3):194-205.
10. Kaufman CL, Williams M, Ryle LM, Smith TL, Tanner M, Ho C. Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: Uptake and durability. Transplantation. 2003;76(7):1043-1046.
11. Sun S, Zeng H, Robinson DB, Genove G, Morel PA. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. 2004;126(1): 273-279.
12. Ahrens ET, Feili-Hariri M, Xu H, et al. Receptor-mediated endocytosis of iron-oxide particles provides eff icient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med. 2003;49(6): 1006-1013.
13. Jing M, Liu XQ, Liang P, et al. Labeling neural stem cells with superparamagnetic iron oxide in vitro and tracking after implantation with MRI in vivo. Chin Med J. 2004;84(16):1386-1389.
14. Dodd CH, Hsu HC, Chu WJ, et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J Immunol Methods. 2001;256(1-2):89-105.
15. Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8(+)T-cells to the pancreas in real time. Diabetes. 2004;53(6):1459-1466.
16. Pouliquen D, Gallois Y. Physicochemical properties of structured water in human album in and gammaglobulin solutions. Biochimie. 2001; 83(9):891-898.
17. Leonard F, Kulkarni RK, Brandes G, et al. Synthesis and degradation of poly(alkyl a-cyanoacrylate). J Appl Polym Sci. 1966;10(2):259-272.
18. Lockman PR, Koziara J, Roder KE, et al. In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles. Pharm Res. 2003;20(5):705-713.
19. Okon E, Pouliquen D, Okon P, et al. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study. Lab Invest. 1994;71:895-903.